Lupin signs distribution agreement with Celnova for orphan drug NaMuscla
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Developed in consultation with clinicians and patients for an enhanced user experience
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Subscribe To Our Newsletter & Stay Updated